TELA Bio (TELA) Operating Income (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.33% |
| Dec 31, 2025 | 11.99% |
| Sep 30, 2025 | 16.82% |
| Jun 30, 2025 | 13.28% |
| Mar 31, 2025 | -158.88% |
| Dec 31, 2024 | 289.90% |
| Sep 30, 2024 | 19.06% |
| Jun 30, 2024 | -139.74% |
| Mar 31, 2024 | 60.69% |
| Dec 31, 2023 | -20.60% |
| Sep 30, 2023 | 1.75% |
| Jun 30, 2023 | 7.93% |
| Mar 31, 2023 | -19.23% |
| Dec 31, 2022 | 0.51% |
| Sep 30, 2022 | 7.33% |
| Jun 30, 2022 | -3.99% |
| Mar 31, 2022 | -28.61% |
| Dec 31, 2021 | -6.06% |
| Sep 30, 2021 | 1.29% |
| Jun 30, 2021 | -0.58% |
| Mar 31, 2021 | -7.74% |
| Dec 31, 2020 | 1.69% |
| Sep 30, 2020 | -32.85% |
| Jun 30, 2020 | 20.51% |
| Mar 31, 2020 | -11.55% |
| Dec 31, 2019 | -51.09% |
| Sep 30, 2019 | 10.33% |
| Jun 30, 2019 | 16.99% |
| Mar 31, 2019 | 5.78% |
| Dec 31, 2018 | -117.83% |